Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Small Cell Lung Cancer Limited Stage × Cisplatin × Clear all

Phase

Phase NA 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Uterine Cervical Neoplasms 10 Nasopharyngeal Carcinoma 7 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Recurrence 4 Carcinoma, Non-Small-Cell Lung 4 Urinary Bladder Neoplasms 3 Ovarian Neoplasms 3 Osteosarcoma 3 Nasopharyngeal Neoplasms 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Neuroblastoma 2 Neoplasms 2 Lung Neoplasms 2 Fallopian Tube Neoplasms 2 Esophageal Squamous Cell Carcinoma 2 Central Nervous System Neoplasms 2 Carcinoma, Squamous Cell 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vomiting 1 Tongue Neoplasms 1 Teratoma 1 Solid Tumor Cancer 1 Small Cell Lung Carcinoma 1 Small Cell Lung Cancer Limited Stage 1 Pleural Effusion, Malignant 1 Peritoneal Neoplasms 1

Interventions

Drug Therapy 2 Etoposide 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03214003 2023-06-22

TRISS

Peking University Cancer Hospital & Institute

Phase NA Completed

Small Cell Lung Cancer Limited Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡